Inside Ginkgo Biowork's $400 million R&D space in Boston Ginkgo BioworksTopline: $4.2 billion synthetic biology powerhouse Ginkgo Bioworks is giving $25 million worth of resources in their $400 million R&D facility to public and private teams working to cure, prevent and treat the novel coronavirus. wrote Forbes’ Ginkgo’s 100,000-square-foot facility located in Boston’s Seaport neighborhood supports big names like Roche and Bayer. The fastest way to do that was to throw it for free at people.”Background: Ginkgo Bioworks is the largest user of lab-printed DNA and has $719 million in funding. It was founded in 2008 by Tom Knight, Jason Kelly, Reshma Shetty, Barry Canton and Austin Che, who met at MIT. For more on Ginkgo, see Forbes’ magazine feature “The Life Factory” from August 2019.

Source: Forbes March 20, 2020 20:48 UTC